Fig. 1From: Intravenous and oral copper kinetics, biodistribution and dosimetry in healthy humans studied by [64Cu]copper PET/CTWhole-body PET images (maximum intensity projection) showing the biodistribution of 64Cu after intravenous (upper panels) and oral (lower panels) administration in two healthy individuals (IV4 and O2). PET imaging was performed 1.5, 6, and 20 h after administration. Arrows identify most visible source organsBack to article page